Navigation Links
Clinical Trials for Lupus Underway After Decades of Drought
Date:10/3/2007

Free Patient Education Campaign Urges Enrollment

LOS ANGELES, Oct. 3 /PRNewswire/ -- For the first time in decades, a significant number of clinical trials are being conducted to seek a treatment, perhaps even a cure, for lupus, a chronic and potentially fatal autoimmune disease that affects more than 1.5 million Americans -- 10,000 in Los Angeles County alone.

A key question that clinical trials answer is, "Will this drug help people and be safe to take?" The question is urgent for people with lupus, because no major new treatments have been approved for the disease in nearly 50 years, and existing medicines are toxic and fraught with side effects.

Until recently, there weren't even trials for people with lupus to enroll in; only recently, with breakthroughs in understanding why the immune system turns against itself in lupus, are new ideas for treatments making their way into the drug approval pipeline.

Fifteen clinical trials in lupus are underway in the Los Angeles area at Cedars-Sinai Medical Center, and an additional 10 are currently recruiting people with lupus. Physicians estimate that 1 in 5 people with the chronic and difficult-to-diagnose illness are not even aware that they are sick with lupus, according to Daniel Wallace, MD, clinical professor of medicine and attending physician in the Division of Rheumatology at Cedars-Sinai. Dr. Wallace is chief investigator at the lupus clinical trial center there.

Lupus Together for Clinical Trials Today, a free patient education program presented by Lupus LA that explains clinical trials for lupus, is scheduled for this Thursday, Oct. 4, from 5:50 to 8 p.m., in the Garden Room at the Veterans Memorial Building, 4117 Overland Ave., Culver City. Registration and a buffet dinner are from 5:30 to 6:30. Pre-registration is required; call Lupus LA at 310-652-7770.

Dr. Wallace and Jennifer Grossman, MD, assistant professor of medicine at UCLA Medical Center, will explain the clinical trial process, why these trials are so important for finding new treatments for lupus, and what is expected of participants. People interested in enrolling will also be given a chance to speak with others who have gone through the process.

"It's important to be informed about the clinical trial process and weigh the pros and cons of participating," Dr. Wallace said. "New therapies that can be identified in clinical trails are critical in the search for a better life for people with lupus. Physicians and scientists are committed to finding these breakthrough treatments. People with lupus are needed, too, as partners in this quest."

Lupus Together for Clinical Trials Today is a campaign of the Lupus Research Institute's National Coalition, a network of regional leaders in lupus. The Institute is the only national nonprofit organization singularly devoted to innovative science in lupus. Its official site for the new clinical trials campaign, http://www.LupusTrials.org, has logged more than 14,000 visitors since it launched in late spring. The campaign is supported in part by unrestricted educational grants from Aspreva Pharmaceuticals and Genentech/Biogen Idec.

About Lupus LA

Lupus LA is dedicated to supporting new science in lupus, and as a National Coalition member partners with the Lupus Research Institute (http://www.LupusResearchInstitute.org) to fund the innovative research needed to prevent, treat, and cure lupus. Lupus LA promotes lupus awareness and education, and is committed to serving the needs of people with lupus and their families in Los Angeles County. Contact Lupus LA at http://www.LupusLA.org, 9220 Sunset Blvd., Suite 200, Loa Angeles, CA. 90069, 310-657-5667.


'/>"/>
SOURCE Lupus LA
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. How do patients benefit of clinical trials
2. Magnetic resonance angiography in clinical medicine
3. Clinical trials need to be more frank
4. AEternas acquisition of Zentaris being followed up with its new product pipeline and clinical development strategy
5. Physicians Lack Clinical Guidelines For Treating Elderly With Multiple Illnesses
6. The Growing Rise In Clinical Research Could Lead To A Compromise In Quality Of Research And Ethics
7. Clinical Comparisons Between ADHD Drugs Are Less
8. Outsourcing clinical trials to India
9. Erectile dysfunction: an early warning sign of clinically silent coronary artery disease?
10. India to maintain Public domain Registry database of clinical trials conducted in India.
11. A Novel System For Clinical Banking Of Umbilical Cord Blood
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2017)... , ... January 23, 2017 , ... ... and high-level training standards for healthcare treatment providers who treat the full spectrum ... Presidents Council. , The Presidents Council consists of the leading eating disorder ...
(Date:1/23/2017)... ... January 23, 2017 , ... Sharon Kleyne, America’s leading water researcher, ... listeners about the benefits of making new water infrastructure a number one priority. “As ... that we expect water infrastructure to become a top priority of our new political ...
(Date:1/23/2017)... ... January 23, 2017 , ... ... Crystallization in Process Chemistry by Applying Simple PAT Tools . , ... to isolate and purify the desired product. Chemists now spend more time ...
(Date:1/23/2017)... ... January 23, 2017 , ... "ProRandom is a set of camera tools that allow ... looks in Final Cut Pro X," said Christina Austin - CEO of Pixel Film Studios. ... layers of text with video footage. ProRandom works by using a virtual camera to ...
(Date:1/23/2017)... ... 23, 2017 , ... Gynecology Associates of Gwinnett (GAoG) has ... for women of all ages. The staff of Gynecology Associates of Gwinnett ... from routine health screenings to diagnosing and treating female concerns including menopause, urinary ...
Breaking Medicine News(10 mins):
(Date:1/21/2017)... , Jan. 20, 2017 ARMO BioSciences, ... clinical data on the Company,s lead investigational immuno-oncology drug ... co-sponsored by the American Society of Clinical Oncology (ASCO), ... Francisco, CA. "AM0010 induces ... CD8 + T cells in the blood and ...
(Date:1/20/2017)... 2017 Research and Markets has announced ... ([CBC, HGB/HCT, BMP, BUN Creatinine, Electrolyte Testing, HbA1c Testing, Comprehensive Metabolic ... Forecasts, 2013 - 2024" report to their offering. ... The global clinical laboratory ... Introduction of innovative solutions on the grounds of maximum ...
(Date:1/20/2017)... Research and Markets has announced the addition of the ... to their offering. ... This research service on the global pharmaceutical stability testing market ... of the key participants in the market. The ... 2020. The market is expected to grow at a CAGR of ...
Breaking Medicine Technology: